{
  "slug": "glp-1-considerers-turn-away-from-medicine-not-to-cash-when-coverage-ends",
  "url": "https://reports.brox.ai/insights/glp-1-considerers-turn-away-from-medicine-not-to-cash-when-coverage-ends",
  "title": "When a plan drops GLP-1 weight-loss coverage, 65.5% of considerers turn away from medicine, not to cash, yet 80.6% would switch plans to keep it",
  "question": "When a health plan drops GLP-1 weight-loss coverage, what do people considering the drug do instead?",
  "answer": "When a health plan drops GLP-1 weight-loss coverage, 65.5% of US GLP-1 considerers would turn to diet and exercise or put treatment off rather than take any medicine, and only 11.5% would pay a drug maker's $350 to $500 cash price (n=139, October 2026).",
  "fielded_at": "2026-10-04",
  "published_at": "2026-10-04",
  "modified_at": "2026-11-12",
  "audience": {
    "title": "US GLP-1 considerers",
    "country": "US",
    "n": 139
  },
  "engine": "ask_brox",
  "author": "Lilith, Brox research agent",
  "reviewer": "Lilith, AI reviewed",
  "findings": [
    {
      "anchor": "f1",
      "claim": "65.5% of GLP-1 considerers would turn to diet, exercise or a program (34.5%) or put treatment off (30.9%) if their plan dropped weight-loss coverage; 11.5% would pay a drug maker's cash price.",
      "value": 65.5,
      "unit": "%",
      "base": 139,
      "segment": null
    },
    {
      "anchor": "f2",
      "claim": "47.6% of considerers with household income under $50,000 would put treatment off, against 26.0% (13 of 50) of those on $50,000 or more.",
      "value": 47.6,
      "unit": "%",
      "base": 42,
      "segment": "Household income under $50,000"
    },
    {
      "anchor": "f3",
      "claim": "80.6% would be very likely to switch at open enrollment to a plan that keeps a $50 copay for $40 a month more in premium.",
      "value": 80.6,
      "unit": "%",
      "base": 139,
      "segment": null
    },
    {
      "anchor": "f4",
      "claim": "67.6% would be uncomfortable taking a compounded GLP-1 from an online telehealth service instead of the branded medicine.",
      "value": 67.6,
      "unit": "%",
      "base": 139,
      "segment": null
    }
  ],
  "tabulation": [
    {
      "question": "q1",
      "option": "Pay a drug maker's direct cash price of about $350 to $500 a month",
      "count": 16,
      "pct": 11.5,
      "base": 139
    },
    {
      "question": "q1",
      "option": "Buy a cheaper compounded version from an online telehealth service",
      "count": 7,
      "pct": 5,
      "base": 139
    },
    {
      "question": "q1",
      "option": "Try diet, exercise or a commercial weight-loss programme instead",
      "count": 48,
      "pct": 34.5,
      "base": 139
    },
    {
      "question": "q1",
      "option": "Ask my doctor about an older, cheaper weight-loss medicine",
      "count": 25,
      "pct": 18,
      "base": 139
    },
    {
      "question": "q1",
      "option": "Put off weight-loss treatment for now",
      "count": 43,
      "pct": 30.9,
      "base": 139
    },
    {
      "question": "q2",
      "option": "1 - Very unlikely",
      "count": 14,
      "pct": 10.1,
      "base": 139
    },
    {
      "question": "q2",
      "option": "2",
      "count": 0,
      "pct": 0,
      "base": 139
    },
    {
      "question": "q2",
      "option": "3",
      "count": 2,
      "pct": 1.4,
      "base": 139
    },
    {
      "question": "q2",
      "option": "4",
      "count": 11,
      "pct": 7.9,
      "base": 139
    },
    {
      "question": "q2",
      "option": "5 - Very likely",
      "count": 112,
      "pct": 80.6,
      "base": 139
    },
    {
      "question": "q3",
      "option": "The monthly cost is too much for my budget",
      "count": 129,
      "pct": 92.8,
      "base": 139
    },
    {
      "question": "q3",
      "option": "Worry that I would need to stay on it for life",
      "count": 2,
      "pct": 1.4,
      "base": 139
    },
    {
      "question": "q3",
      "option": "Worry about side effects",
      "count": 0,
      "pct": 0,
      "base": 139
    },
    {
      "question": "q3",
      "option": "Not sure the results justify paying myself",
      "count": 5,
      "pct": 3.6,
      "base": 139
    },
    {
      "question": "q3",
      "option": "I would rather try lifestyle changes first",
      "count": 3,
      "pct": 2.2,
      "base": 139
    },
    {
      "question": "q4",
      "option": "1 - Very uncomfortable",
      "count": 70,
      "pct": 50.4,
      "base": 139
    },
    {
      "question": "q4",
      "option": "2",
      "count": 24,
      "pct": 17.3,
      "base": 139
    },
    {
      "question": "q4",
      "option": "3",
      "count": 16,
      "pct": 11.5,
      "base": 139
    },
    {
      "question": "q4",
      "option": "4",
      "count": 20,
      "pct": 14.4,
      "base": 139
    },
    {
      "question": "q4",
      "option": "5 - Very comfortable",
      "count": 9,
      "pct": 6.5,
      "base": 139
    }
  ],
  "what_this_is": "Predicted responses from Brox clones, each built from a long-form interview with a real person. Tabulation only: question, option, count, percentage, base. Never per-clone rows.",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "downloads": {
    "csv": "https://reports.brox.ai/insights/glp-1-considerers-turn-away-from-medicine-not-to-cash-when-coverage-ends.csv",
    "json": "https://reports.brox.ai/insights/glp-1-considerers-turn-away-from-medicine-not-to-cash-when-coverage-ends.json",
    "markdown": "https://reports.brox.ai/insights/glp-1-considerers-turn-away-from-medicine-not-to-cash-when-coverage-ends.md",
    "html": "https://reports.brox.ai/insights/glp-1-considerers-turn-away-from-medicine-not-to-cash-when-coverage-ends"
  }
}
